Society
Ozempic Changes Lives. But Not Everyone's in the Same Way
GLP-1 analogues have transformed the treatment of obesity and the lives of many patients. But the popularity of Ozempic and Mounjaro also reveals something uncomfortable about a new ideal of thinness, class inequality, and a market that sells hope at a high price. By Michał Kuźmiński "Everyone looks